Nickel-Catalyzed Kumada Cross-Coupling Reactions of Tertiary Alkylmagnesium Halides and Aryl Bromides/Triflates
作者:Amruta Joshi-Pangu、Chao-Yuan Wang、Mark R. Biscoe
DOI:10.1021/ja202769t
日期:2011.6.8
We report a Ni-catalyzed process for the cross-coupling of tertiary alkyl nucleophiles and aryl bromides. This process is extremely general for a wide range of electrophiles and generally occurs with a ratio of retention to isomerization >30:1. The same procedure also accommodates the use of aryl triflates, vinyl chlorides, and vinyl bromides as the electrophilic component.
我们报告了一种用于叔烷基亲核试剂和芳基溴化物交叉偶联的 Ni 催化过程。这个过程对于范围广泛的亲电子试剂来说是非常普遍的,并且通常在保留与异构化的比率 > 30:1 的情况下发生。相同的程序也适用于使用芳基三氟甲磺酸酯、氯乙烯和溴乙烯作为亲电子组分。
[EN] TRIAZOLOPYRIDINE ETHER DERIVATIVES AND THEIR USE IN NEUROLOGICAL AND PYSCHIATRIC DISORDERS<br/>[FR] DÉRIVÉS D'ÉTHER DE TRIAZOLOPYRIDINE ET LEUR UTILISATION CONTRE DES TROUBLES NEUROLOGIQUES ET PYSCHIATRIQUES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2015042243A1
公开(公告)日:2015-03-26
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds modulate the mGluR2 receptor and may be useful for the treatment of various disorders of the central nervous system.
The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof:
The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, itch, and neurogenic inflammation.
TRIAZOLOPYRIDINE ETHER DERIVATIVES AND THEIR USE IN NEUROLOGICAL AND PYSCHIATRIC DISORDERS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160237081A1
公开(公告)日:2016-08-18
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds modulate the mGluR2 receptor and may be useful for the treatment of various disorders of the central nervous system.